FDA vaccine oversight is shifting, with increased scrutiny and mixed messaging sparking concerns among health experts.

The President Donald Trump administration's request for Novavax Inc. to conduct new clinical trials for its COVID-19 vaccine has created uncertainty across the vaccine industry, potentially affecting ...

Kennedy won Senate confirmation to his job, in part, by promising not to change the nation’s vaccine schedule. Since taking ...

In a recent interview, FDA Commissioner Marty Makary said there “should be nothing political about the FDA.” Recent actions ...

Novavax is working with the FDA to meet additional requirements and hopes to secure full approval as soon as possible.

Former government health officials fear the Trump administration is moving to slow-walk vaccine approvals, including by ...

Federal regulators have requested that Novavax conduct an additional randomized clinical trial of its COVID-19 vaccine, a costly demand that could threaten the company’s ability to comply, The Wall ...

WASHINGTON (AP) — Another federal judge in Washington has expressed skepticism on the legality of President Donald Trump’s ...